For nearly a year, public health agencies at the federal, state and local levels have been investigating what has been described as a “national outbreak” of E-cigarette, Vaping Associated Lung Injury (EVALI). EVALI is the inflammation of the lungs, producing pneumonia like symptoms as a result of inhaling the substances found in vape cartridges. For young and adolescent consumers, the use of vaping devices as a delivery system for both nicotine and Delta-9 tetrahydrocannabinol (THC) has increased in popularity but, has also increased the health risks to the consumer.
The Centers for Disease Control and Prevention (CDC) has just released a new study in the Journal of the American Medical Association (JAMA) for Pediatrics. This study focuses on the behaviors of adolescent use, suggestions for those involved in patient care, and a call for further EVALI research.
The full CDC study can be accessed at the following JAMA citation.